| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |